In summary, the studies described here show that CXCR7 is a hypoxia-responsive mediator of SDF-1α-induced glioma cell migration and support the development of therapeutic agents for the pharmacological inhibition of CXCR4 and CXCR7 to control glioma cell migration. Here, CXCL12 is linked to central nervous system cancer.